Charles Schwab Investment Management Inc Inovio Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$0.38 - $0.58 $428,660 - $654,270	-1,128,053 Reduced 89.46%	132,910 $51,000
Q2 2023 Aug 09, 2023	SELL	$0.39 - $0.94 $195,565 - $471,362	-501,449 Reduced 28.45%	1,260,963 $567,000
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $85,469 - $206,640	-108,189 Reduced 5.78%	1,762,412 $1.45 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $74,287 - $131,715	52,686 Added 2.9%	1,870,601 $2.92 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $291,970 - $490,721	175,886 Added 10.71%	1,817,915 $3.14 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $160,452 - $443,471	111,425 Added 7.28%	1,642,029 $2.84 Million
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $163,020 - $285,422	54,889 Added 3.72%	1,530,604 $5.5 Million
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $124,919 - $186,753	25,034 Added 1.73%	1,475,715 $7.36 Million
Q3 2021 Nov 16, 2021	BUY	$7.16 - $9.69 $122,142 - $165,301	17,059 Added 1.19%	1,450,681 $10.4 Million
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $406,476 - $654,407	65,245 Added 4.77%	1,433,622 $13.3 Million
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $2.4 Million - $4.63 Million	272,900 Added 24.91%	1,368,377 $12.7 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $164,636 - $248,891	19,369 Added 1.8%	1,095,477 $9.7 Million
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $927,438 - $2.62 Million	96,911 Added 9.9%	1,076,108 $12.5 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $1.51 Million - $6.7 Million	211,383 Added 27.53%	979,197 $26.4 Million
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $605,956 - $2.87 Million	203,341 Added 36.02%	767,814 $5.71 Million
Q4 2019 Feb 07, 2020	BUY	$1.97 - $3.72 $1,270 - $2,399	645 Added 0.11%	564,473 $1.86 Million
Q3 2019 Nov 08, 2019	BUY	$2.05 - $3.02 $168,842 - $248,733	82,362 Added 17.11%	563,828 $1.16 Million
Q2 2019 Aug 09, 2019	SELL	$2.29 - $4.1 $47,893 - $85,747	-20,914 Reduced 4.16%	481,466 $1.42 Million
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $36,766 - $56,140	11,008 Added 2.24%	502,380 $1.87 Million
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $21,904 - $34,405	5,631 Added 1.16%	491,372 $1.97 Million
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $156,388 - $222,614	39,895 Added 8.95%	485,741 $2.7 Million
Q2 2018 Aug 08, 2018	BUY	$3.88 - $5.16 $130,239 - $173,205	33,567 Added 8.14%	445,846 $1.75 Million
Q1 2018 May 07, 2018	BUY	$4.05 - $5.69 $312,971 - $439,706	77,277 Added 23.07%	412,279 $1.94 Million
Q4 2017 Jan 17, 2018	BUY	$4.13 - $6.68 $9,664 - $15,631	2,340 Added 0.7%	335,002 $1.38 Million
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $1.78 Million - $2.12 Million	332,662	332,662 $2.11 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account